Arnon Chait, Chief Executive Officer of Cleveland Diagnostics, a Cleveland Clinic Innovations portfolio company, authors this piece on the continuing inequalities in the diagnosis and results of prostate cancer. Dr. Chait shares that the necessity to improve patient access to effective screening techniques is crucial.
Through the collaboration, Cleveland Clinic’s critical care and non-critical care central patient monitoring platforms will be integrated with Masimo’s Hospital Automation platform. The collaboration will entail joint initiatives on predictive analytics and artificial intelligence-based algorithms.
Cleveland Clinic Innovations leaders share insights into the digital technologies currently transforming the healthcare industry. Facing unprecedented challenges, including escalating operational costs and severe workforce shortages, these pioneering technologies are proving essential, delivering practical solutions that enhance efficiency and patient care.
Newly published Cleveland Clinic-led research first to use medical scans to inform dose delivery